Dr. Reddy’s, RDIF secure DCGI’s approval for Sputnik V vaccine trial in India

This article was originally published here

The approval from an Indian regulator allows conducting an adaptive phase 2/3 human clinical trial for Sputnik V vaccine in the country. According to RDIF, the multi-centre and

The post Dr. Reddy’s, RDIF secure DCGI’s approval for Sputnik V vaccine trial in India appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply